Despite efforts to promote tissue repair, many wounds heal slowly, do not heal or deteriorate. Management of these chronic wounds is a growing problem. Innovation and cost cutting is key to current health policy and therefore clinicians should be taking advantage of emerging technologies that can improve outcomes for patients while reducing costs. Accel-Heal is an innovative electroceutical device that uses a patented synapse sequence programmed to deliver a specific series of electric energy interactions through the skin to manipulate gene expression and modify specific physiological functions in dermal tissue, improving and accelerating healing. This article examines the use of Accel-Heal in three case studies.